The polycystic ovary syndrome: pathogenesis and treatment.
about
A two-dimensional electrophoresis reference map of human ovaryGnRH pulses--the regulators of human reproduction.Review of nonsurgical and surgical treatment and the role of insulin-sensitizing agents in the management of infertile women with polycystic ovary syndrome.How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?Insulin-like growth factor-I enhances luteinizing hormone binding to rat ovarian theca-interstitial cells.Nonclassical congenital adrenal hyperplasia and the polycystic ovarian syndrome.Cholesterol side-chain cleavage gene expression in theca cells: augmented transcriptional regulation and mRNA stability in polycystic ovary syndromeGenetics of polycystic ovary syndrome: searching for the way out of the labyrinth.Hirsutism in the United Arab Emirates: a hospital studyVirilization in a postmenopausal woman due to ovarian stromal hyperthecosis.Androgen-producing bilateral large cortical adrenal adenomas associated with polycystic ovaries in a young female.Laparoscopic surgery of chronic hyperandrogenic anovulation.Hirsutism: pilosebaceous unit dysregulation. Role of peripheral and glandular factors.Dexamethasone potentiates IGF-I actions in porcine granulosa cells.Hirsutism: evaluation and management.Gonadotropin-releasing hormone agonist as a probe for the pathogenesis and diagnosis of ovarian hyperandrogenism.Diagnostic dilemmas in polycystic ovarian syndrome.Cystogenesis of the ovarian antral follicle of the rat: ultrastructural changes and hormonal profile following the administration of dehydroepiandrosterone.Effects of flutamide on pituitary and adrenal responsiveness to corticotrophin releasing factor (CRF).Adrenal androgenic response to 2-hour ACTH stimulation test in women with PCOS.The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.GnRH analog administration in patients with polycystic ovarian disease.Ovarian stromal hypertrophy in hyperandrogenic women.The role of insulin in ovarian size in patients with the polycystic ovary syndrome.Interrelationship between ultrasonography and biology in the diagnosis of polycystic ovarian syndrome.17-Hydroxyprogesterone response to buserelin testing in the polycystic ovary syndrome.Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: effect of metformin.Comparison between buserelin and dexamethasone testing in the assessment of hirsutism.Reduction of dehydroepiandrosterone sulfate synthesis in women with polycystic ovary syndrome by human menopausal gonadotropin but not purified urinary follicle stimulating hormone: a comparative pilot study.Menstrual irregularities are more common in adolescents with type 1 diabetes: association with poor glycaemic control and weight gain.Effect of prednisolone on serum and follicular fluid androgen concentrations in women with polycystic ovary syndrome undergoing in-vitro fertilization.Polycystic ovary syndrome: What is it? Pathogenetic enigma and therapeutic dilemma.Ovarian morphology and insulin sensitivity in women with bulimia nervosa.Polycystic ovary syndrome and psychiatric morbidity.Polycystic ovarian syndrome: pregnancy outcome following in vitro fertilization-embryo transfer.Results of an open one-year study with Diane-35 in women with polycystic ovarian syndrome.Octreotide effect on ovarian morphology in insulin-resistant PCOS patients following six-month decapeptyl treatment.
P2860
Q28261901-8525920B-2639-435A-83DA-52964ABD350BQ30311330-F24DC461-3253-4302-AD56-B9C6401401D6Q31084944-0D5AD54D-6DCB-48EE-869C-A97EECEF1C62Q34253236-5E209A31-BAF1-45B1-8845-96CF471802FDQ34258799-BE22E230-0EC6-42FA-8701-BCA308BEAC3EQ34350709-A98A74C3-BA50-4555-9FAF-640E756D1172Q34479225-04A77A79-B56D-4DFB-A3D6-8475D6E6BAACQ36182579-B7E09385-6714-48A5-A6C4-40F0422E21B9Q36680647-2D7A034B-FB6F-4B2C-BA12-85A919C108CCQ36682020-78E77C09-3377-4F3F-8250-B0A83AF627FDQ36682483-E82165E4-0E8F-4955-80BE-BECC439A14CCQ36708962-CF92842A-A342-4994-B28B-205B276601EDQ37771103-7556ADF5-C448-4A6A-87F6-A3A4A693CE23Q39395561-026908EC-3599-4EC4-BAB7-A2610D3E4460Q40447986-1BEA5248-5615-495F-BB08-57B1B934AC2FQ40821600-4CD830E8-26B2-4628-95E1-A2D05AB4B8C2Q40821621-6C73D1C4-1DE8-4FB0-94B3-6BB7AAD21375Q42456808-03898676-DD33-40AF-815D-20A932EA788FQ42463314-99A33F77-FD08-45E7-BF2D-130A3C978218Q42463324-83BAE691-B722-412E-AA0D-32CC26D5EA66Q42476947-A15A57BA-C156-4EE0-92FB-D4B95D651BCCQ42479568-CC54B3CC-FED8-4C14-A8E3-488AFD1785ECQ42488181-C419D3C5-F77C-40FC-924D-87D37F0E5C75Q42488875-B3409430-D07A-4B38-8FBE-E188D515853AQ42505623-17875036-8824-4036-9D47-9AF145ADCB68Q42508472-1E6FC02A-6AFB-4C18-AA14-F8B64E8BA7F1Q42513501-B0E9B3D4-1410-461B-9E28-DE593C72B367Q43909056-C98E94C9-2984-4EAC-B41F-746A272CF437Q45205627-59547E61-9E70-42D4-9EB5-B00D8C49655FQ47374203-C4F39E5F-E22F-4DB1-843A-82543DBB776DQ48916529-B2EAB268-C271-4FE2-8ADE-D1310C39BFB9Q51092931-A0105B8E-EC71-4CF1-8CE5-F6142A2FA81EQ51585424-8F2C757D-7245-4CFD-8243-01CFF8087F6BQ52035966-C7F64542-35F6-4FF1-B802-7E53627C43F5Q52341055-56AFAB55-A7E3-4D17-B1C7-D74BCD841E52Q54047721-F79367A5-2D4A-4A3C-A453-6C0C29E7FEB0Q54213056-8ADFB7F9-7608-46A7-BF2A-16F76329FA94
P2860
The polycystic ovary syndrome: pathogenesis and treatment.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
The polycystic ovary syndrome: pathogenesis and treatment.
@en
type
label
The polycystic ovary syndrome: pathogenesis and treatment.
@en
prefLabel
The polycystic ovary syndrome: pathogenesis and treatment.
@en
P1476
The polycystic ovary syndrome: pathogenesis and treatment.
@en
P2093
Rosenfield RL
P304
P356
10.7326/0003-4819-110-5-386
P407
P577
1989-03-01T00:00:00Z